A B S T R A C T Polymorphonuclear leukocytes from humans and mice with the Chediak-Higashi syndrome were characterized by spin label electron spin resonance spectrometry. Our results suggest that cells from afflicted mice and humans have membranes more fluid than controls. Order parameters for a spin label that probes near the membrane surface were 0.652 for normals and 0.645 for two Chediak-Higashi patients. Cells from Chediak-Higashi mice showed similar differences, as did isolated plasma memiibrane fractions. An increased membrane fluidity was also detected with a spin label that probes deeper in the bilayer. In vitro treatment of Chediak-Higashi mouse cells with 0.01 M ascorbate increased the order parameter to normal levels. In vitro incubation of mouse Chediak-Higashi cells with glucose oxidase increased the order parameter, similar to the effect of ascorbate. This increase was abolished when catalase was added to the incubation medium. In vitro incubation with dibutyryl cyclic guanosine monophosphate (1 ,uM to 0.1 mM) did not normalize order parameters. These results indicate that fluidity of Chediak-Higashi cell membranes was affected by treatments expected to alter the oxidation: reduction potential of the environment but was not affected by treatments expected to alter the ratio of intracellular cyclic nucleotides. The latter treatment would affect microtubule assembly. Therefore, it appears that the membrane fluidity abnormalities as demonstrated by electron spin resonance and the earlier demonstrated microtubule dysfunction s characteristic of Chediak-Higashi cells are coexistinig defects and are probably not directly related.
INTRODUCTION
The Chediak-Higashi syndrome (CHS)' of man is an autosomal recessive disorder in which polymorphonuclear leukocytes (PMN) exhibit a variety of abnormalities (1) . A similar disorder has been described in mice (2) . Phenotypic characteristics ofthe syndrome include: (a) decreased pigmentation brought about by aggregation of melanin granules; (b) enlarged lysosomnes; and (c) recurrent problems with bacterial infections secondary to disorders of PMN chemotaxis, degranulation, adherence, and bacterial killing. Treatment with ascorbate corrects these functional defects of CHS PMN (3) (4) (5) .
Membranie abnormiialities may contribute to these various defects. Concanavalin A (Con A) treatment of CHS PMN reveals spontaneous formation of polar caps of surf:ace glycoproteins (6, 7) , suggesting that these cells have abnormal mobility of memnbranie constituents. Normal cells do not undergo capping unless treated with colchicine, which inhibits microtubule (MT) assemnbly. Thus, membrane alterations in CHS may coexist along with MT dysfutnction or they may be directly related to it.
In this study we have uised spin label electron spinl resonance (ESR) spectrometry to characterize abnormalities in CHS PMN memnbranes. Ouir restults indicate that these cells from CHS mice have an altered membrane environmenit compared to those from normal animals. Further, study of PMN fiomn patients with CHS suggests that this same membrane alteration occurs in human cells.
NI ETHO DS Chemicals. Dibutyryl cyclic GMP (cGMP), glucose oxidase, and catalase were obtained from Sigma Chemical Co. (St. Louis, Mo.). The spinl labels ( Fig. 1 ) 2-(3-carboxvpropyl)-4,4-dimethyl-2-tridecyl-3-oxazolidinyloxyl (5DS) and 2-(10-carboxydecyl)-2-hexyl-4,4-dimethyl-3-oxazolidinyloxyl (12DS) were purchased from Syva (Palo Alto, Calif.). Stock solutions of spin labels at 5 mMN were made up in ethanol.
Animals. Normal (C576J +/+) and CHS (C576J bg/bg) mice were obtained from The Jackson Laboratory (Bar Harbor, Maine).
Human subjects. Two white female patients were studied.
The diagnosis of CHS had been established by clinical history and examination and in the presence of giant lysosomes in PXIN. Reports of the success of ascorbic acid therapy with these patients have been made (3, 5) . Before the present ESR studies (2 m11o for patient 1; 5 wk for patient 2) ascorbic acid treatment had been discontinued as a check on the continued efficacy of this therapeutic approach. Degranulation, bacterial killing, and chemotaxis have been demonstrated to return to abnormal levels 4 wk after cessation of ascorbic acid therapy (3). Cells from normal white adult females were used as controls for our present investigation. Protocols involving human subjects were approved by the Indiana University/Purdue University-Indianapolis Coimmittee on Protection of Human Subjects. Informed consent was obtained and the research was conducted according to the Declaration of Helsinki. Preparation and incubation of PMN. Peritoneal exudate leukocytes were elicited from mice by intraperitoneal injection of 2-3 ml 12% soclium caseinate (Difco Laboratories, Detroit, NMich.). 18 h after injection, mice were sacrificed and peritoneal contents collected. Cells were suspended in icecold 0.85% NaCl and centrifuged (200 g, 10 min, 4°C), resuspended and washed twice in saline. Final suspension (3.5 to 4.5 x 10(7 leukocvtes/ml) was in modified Hanks' solution (8) (HBG) with addled glucose (0.1%) and bovine serum albumin (0.01%). Typically suspensions were 80-90% PMN. Human PMN were prepared from venous blood bv dextran sedimentation and separation by Ficoll-Hypaque gradient (Pharmacia Fine Chemicals, Piscataway, N. J.) (9) . Final suspension was in HBG at 3.0 x 1(7 leukocvtes/ml vith 98% of cells being PM1N.
1 ml PMN suspenision was placed in a snap-cap tube. For somile experiments additions of ascorbate, cGMP, glucose oxidase, or catalase were made. Controls received HBG in place of these agents. Incubation was carried out at 37°C for 15 min with tumbling (12 rpm). In experiments with ascorbate, cells were washed with 9 ml HBG after incubation and resuspended in 1 ml HBG after centrifugation ( 3 ,ul of stock 5DS had previously been evaporated. The membrane was taken up in a 100-,ul capillary, and the distal tip of the capillary was heat sealed and cooled. After centrifugation to displace the membranes into the sealed tip, the tube was placed in the ESR spectrometer and the spectrum recorded.
ESR data acquisition and analysis. ESR spectra were obtained on a standard balanced-bridge spectrometer with diode detection operating at 9.1 GHz. Phase-sensitive detection with a 50-kHz magnetic field modulation frequency was used. Sample heating and broadening of spectral lines were avoided by recording all spectra at low microwave power (12 mW) incident on the Varian V4535 large access cavity (Varian Associates, Palo Alto, Calif.). A peak-to-peak modulation amplitude of 1.5 gauss (G) was used for 5DS-labeled PMN and 0.5 G for 12DS-labeled cells. Other appropriate values were sometimes used after determination that comparisons between samples were independent ofamplitude at the values used. All instrument settings were identical for a particular set of samples being compared. First derivative absorption spectra were recorded with a 100-G field sweep, a scan time of 5 min, and a time constant of 0.2 s. The magnetic field sweep was calibrated with a NMR gaussmeter (Varian Associates, Palo Alto, Calif.). Sample temperature was monitored with a thermocouple, and was maintained to within +0.5°C of the desired temperature (usually 25°C) through use of a chilled or heated N2 gas-flow system.
Two spectra from each sample were recorded and the resultant parameters averaged. All samples were coded and read blind. For experiments in which identical samples were run on the same day, the standard procedures for determining mean, S error, and SD were used. For experiments in which several samples were measured and data from several days were available, a two-way analysis of variance was carried out. All P values given herein are for the probability that a null hypothesis is true.
The order parameter (S), a measure of spin label order and motion, was calculated (12, 13) for 5DS-labeled PMN.
TI, + 2T1 + 2C where C = 1.4-0.053 (T1l -T'). The measurement of the hyperfine spitting parameters TI, (T parallel) and TL (T' perpendicular) from a typical ESR spectrum of 5DS-labeled PMN from Chediak-Higashi mice is shown in Fig. 2A . As flexibility of the hydrocarbon chain of the spin label decreases, the order parameter increases. This implies that as the environment surrounding the nitroxide group of the label becomes more ordered (i.e., less fluid), the order parameter increases. The theoretical limits of S are S = 0 for a completely fluid, isotropic system and S = 1 for a completely rigid or ordered environment. Typical values for spin-labeled membranes are from 0.5 to 0.7. Changes in S as small as 0.5% can be shown to be statistically significant at a 95% confidence level (14) .
The class ofspectra resulting from isotropic rapid motion ofa spin label is most amenable to quantitative assessment by the calculation of the rotational correlation time, Tr (15, 16):
The line-width and line-heights necessary for this calculation are obtained from the ESR spectrum as shown in Fig. 2B . 
Because 12DS in PMN membranes has a TC near this limit and also probably has some anisotropic motion, for comparative purposes the 12DS results are reported with an operationally defined, empirical parameter, R,:
s (3) Ri can be related to the degree of spin label motion in the membrane by noting that near 25°C Ri changes by 0.2 G/°C. As the temperature increases, R1 decreases; this suggests that the spin label motion is more rapid and that the membrane environment is more fluid.
RESULTS
PMN prepared from venous blood of human subjects were spin labeled with 5DS. In sets of paired samples, CHS cells consistently had a lower S than did normal cells (Fig. 3) (P < 0.065 for patient 1; P < 0.004 for patient 2). The relatively large number of cells required for our determinations precluded intensive experimentation with PMN of these patients, but the similarity between their cells and those of the CHS mice encouraged us to use cells from these animals in studies designed to help elucidate the molecular and(or) subcellular basis for the fluidity difference.
Peritoneal exudate PMN from normal and CHS mice were labeled with 5DS. Results were similar to those obtained with human PMN; the comparison of order parameters revealed a significant difference (P = 0.003; To explore the possibility that evolution of H202 might be altering fluidity of ascorbate-treated CHS PMN, we incubated cells with glucose oxidase under conditions which should permit H202 generation. Fig.  6 shows the results of these experiments. In the presence of heat-inactivated enzyme the CHS PMN were more fluid than normal cells. Incubation with active glucose oxidase (1 U/ml) increased CHS S values (P < 0.001) compared to untreated CHS cells. They were not significantly different (P > 0. 5 The effect of changes in intracellular levels of a cyclic nucleotide and a microtubule disrupting agent was also examined. The addition of cGMP (0.1 mM to 1 ,M) to 5DS-labeled PMN from normal and from CHS mice had no significant effect on S (Table I) . Similarly, incubation of cells with colchicine (0.1 mM to 1 ,uM) for 30 min failed to affect significantly the order parameter (data not shown).
DISCUSSION
Study of cell membrane fluidity in various disease states has received increasing attention in recent years (17) . Fluorescence polarization studies of leukemic lymphocytes (18) and ESR studies of erythrocytes from muscular dystrophy patients (19, 20) have revealed fluidity abnormalities for these formed elements of the blood. In this study we have used spin label ESR to characterize the membrane fluidity of intact, viable CHS PMN and isolated membrane fractions. Our results suggest that CHS PMN from humans and mice have membranes more fluid that controls. In addition, we modified the membrane fluidity of the CHS PMN in vitro with the addition of ascorbate and a H202-generating system. These effects were observed only in CHS cells and not in the normal controls, wvhich demonstrates that the CHS membranes have altered properties allowing them to respond differently to oxidase treatments. Although ascorbate modified the PMN membrane fluidity in vitro its effect on enhancing PMN function in vivo in CHS patients may be coincidental. 
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The increase in membrane fluidity observed in CHS PMN membrane could be caused by many factors. Those of particular pertinence to the CHS include decreased cholesterol content, a decreased sphingomyelin:lecithin ratio, and an increased degree of unsaturation of membrane fatty acids. A decreased total cholesterol level in the fasting serum of one CHS patient has been reported (21) . Through exchange processes this serum decrease may be reflected in a similar decrease of membrane cholesterol levels. Decreased cholesterol content would be expected to give rise to increased membrane fluidity (17) such as we report here. An accelerated turnover of sphingolipids in CHS leukocytes has been demonstrated (22) , and is consistent with previous reports of a decreased sphingolipid content in CHS PMN membrane (23) and in serum (21) . This decrease, together with the reported concurrent increase in lecithin content (21) , would be expected to give rise to increased membrane fluidity.
Molecular movements within the membrane seem critical to many cellular functions. The lower S values for CHS PMN may reflect the same membrane alterations that lead to the abnormal fusion of azurophilic and specific granules (24, 25) found in these cells. Disordered fluid portions of the membrane may favor fusion. Lucy (26) has suggested that factors which bring about localized regions of micellular lipid arrangements in the bilayer will also favor membrane fusion.
In vitro ascorbate treatment might have resulted in a decrease in membrane fluidity in CHS PMN through a variety of mechanisms. Studies with cells in culture have previously suggested that ascorbate-triggered reactions led to production of H202, which in turn was responsible for membrane alteration (27) . Membranes of PMN high in unsaturated fatty acid content, specifically of arachidonic acid, have greater susceptibility to lipid peroxidation (28) . In phospholipid liposomes ascorbate-induced lipid peroxidation has been showni to increase memlbrane rigidity (29) . If, as we presently believe, the ascorbate effects on CHS fluidity are mediated via H202, a likely biochemical mechanismii is lipid peroxidation and the likely targets include unsaturated fatty acids. Whatever the mechanism, the absence of a marked response to ascorbate treatment by normal PMN, in contrast to CHS PMN, suggests that initially more fluid membranes of CHS cells have an altered in vitro structure or organization which may be the basis, at least in part, of altered function in vivo.
An alternate mechanism for ascorbate effect on fluidity might be related to changes in intracellular levels of cyclic nucleotides. Earlier studies had demonstrated that ascorbate treatmenit resulted in partial correction of the elevated cAMP levels in human CHS cells (3, 5) . Treatment of CHS PMN of either human (30) or mouse (7) with cGMP also normalized function, and it therefore appeared that cAMP:cGCIP ratios might be important in defect repairs. Incubation of PMN in concentrations of cGMP up to 0.1 mM, however, had no significant effect on order parameters of either normal or CHS PMN. Thus, it appeared that participation of ascorbate in oxidation:reduction reactions was more important in altering the fluidity of CHS cells than was any effect related to potential alteration of intracellular cyclic nucleotides.
A role for MT in defects of CHS PMN has been suggested (7) . PMN from CHS subjects undergo spontaneous capping of membrane glycolipids as revealed by treatment with Con A (6, 7). Normal cells show no such tendency unless incubated with agents that prevent MT assembly. Cyclic GMP treatment, which normalized capping in CHS cells (6, 7, 30) , also influenced functions in normal PMN that are colchicine-sensitive, such as lysosomal enzyme release (31) . Electron microscopy revealed an absence of MT assembly in Con Atreated PMN from a CHS patient but normal MT assembly in CHS PMN incubated with cGMP and cholinergic agonists before Con A treatment (32 (33) . It appears that the membrane fluidity abnormalities as demonstrated by electron spin resonance and the earlier demonstrated microtubule dysfunction s characteristic of Chediak-Higashi cells are coexisting defects and are probably not directly related. However, the possible relations aimong abnormial NIT, altered memiibrane properties, and defective PMN function in CHS remain to be elucidated.
